about
Preparation of Two Types of Polymeric Micelles Based on Poly(β-L-Malic Acid) for Antitumor Drug DeliveryTargeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer ActivityTargeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugationPreparation of poly(β-L-malic acid)-based charge-conversional nanoconjugates for tumor-specific uptake and cellular deliverypH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug deliveryStructural and formulation factors influencing pyridinium lipid-based gene transfer.Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs.Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.Lipids and their derivatives: by-products used as essential building blocks for modern drug delivery systems.Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.Hypoxia-targeted siRNA delivery.Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine.Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery.Improving Tumor Specificity and Anticancer Activity of Dasatinib by Dual-Targeted Polymeric Micelles.Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles.MMP2-Sensitive PEG-Lipid Copolymers: A New Type of Tumor-Targeted P-Glycoprotein Inhibitor.Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micellesMMP-Responsive 'Smart' Drug Delivery and Tumor TargetingFolate-targeted pH-sensitive bortezomib conjugates for cancer treatment
P50
Q28554265-F07D34CB-F621-411F-B3C6-3371BDEDC872Q33396381-217A0FDC-C002-4D15-B98C-65FBF5AF0D4FQ33820964-B5F512BE-6283-4321-A6DC-72F3F5D64692Q34389283-5271BC64-3CBA-4F91-9D8D-380C44442C48Q35189737-AD456EF0-A805-4D84-94B4-278B073DCC65Q36653608-0E6B9410-91EF-4DBC-AA7D-1800DE0D41A8Q37190052-41153B60-9444-4441-8763-26B3AC6D4AA0Q37240616-01070C6D-3A4F-4045-B764-00E6F788469CQ37695149-C8077D9C-04E1-4462-A53C-AFB975888A90Q38763461-0515559B-2B73-4559-AB47-315A29EEFB0AQ38859846-FF882832-0932-400B-A483-32480BF8500EQ39044761-EE6D1372-DC98-478A-85B5-AD1D3FA1A249Q39238404-9B98B15E-CEC5-4B5E-A4A2-B361EE1A4730Q39381365-2D783DED-08E2-4452-9FEE-783AE380CBDDQ41807205-110E717B-C692-4E77-9F92-8F4AC900C12DQ42443824-33FBE9B7-F086-4F63-9ACF-5C671F929549Q47405011-D2285439-A6D4-44C5-81EA-7593865EC332Q48132478-42AFFC3C-2E63-45E9-9D4F-B0A73E25766DQ48269666-AE166A52-9F62-47E3-BF83-6CF631B4B11AQ48291398-E40FB009-D8D8-4817-A207-40BB4D57F473Q53787503-3E1D0001-CB2C-4DFD-B74C-3E5B16394D15Q90030754-C410D7D2-77F3-4886-8CD8-904EFFD65F1EQ90390351-6DEF7B34-794F-453F-A3DC-27875033DB78Q92551431-0454BF5A-F512-4DAE-9A67-E618BD28A2F0
P50
description
researcher ORCID ID = 0000-0002-4047-1726
@en
name
Lin Zhu
@ast
Lin Zhu
@en
Lin Zhu
@es
Lin Zhu
@nl
type
label
Lin Zhu
@ast
Lin Zhu
@en
Lin Zhu
@es
Lin Zhu
@nl
prefLabel
Lin Zhu
@ast
Lin Zhu
@en
Lin Zhu
@es
Lin Zhu
@nl
P1153
35773978100
P31
P496
0000-0002-4047-1726